This article has been corrected: Dr. Meiqing Lou is included as a co-corresponding author.
Original article: Oncotarget. 2018; 9:706-717. https://doi.org/10.18632/oncotarget.23091
. 2018 Mar 30;9(24):17255. doi: 10.18632/oncotarget.25063
Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
Fei Shi
1,#, Jinying Zhang
2,#, Hongyu liu
3, Liangliang Wu
3, Hongyu Jiang
4, Qiyan Wu
3, Tianyi Liu
3, Meiqing Lou
1,#, Hao Wu
5,#
Fei Shi
1 Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China
Find articles by Fei Shi
Jinying Zhang
2 Institute of Basic Medicine Science, Chinese PLA General Hospital, Beijing 100853, China
Find articles by Jinying Zhang
Hongyu liu
3 Key Laboratory of Cancer Center, Chinese PLA General Hospital, Beijing 100853, China
Find articles by Hongyu liu
Liangliang Wu
3 Key Laboratory of Cancer Center, Chinese PLA General Hospital, Beijing 100853, China
Find articles by Liangliang Wu
Hongyu Jiang
4 Department of Anesthesiology, Wuxi Third People's Hospital, Wuxi, Jiangsu 214000, China
Find articles by Hongyu Jiang
Qiyan Wu
3 Key Laboratory of Cancer Center, Chinese PLA General Hospital, Beijing 100853, China
Find articles by Qiyan Wu
Tianyi Liu
3 Key Laboratory of Cancer Center, Chinese PLA General Hospital, Beijing 100853, China
Find articles by Tianyi Liu
Meiqing Lou
1 Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China
Find articles by Meiqing Lou
Hao Wu
5 Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
Find articles by Hao Wu
1 Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China
2 Institute of Basic Medicine Science, Chinese PLA General Hospital, Beijing 100853, China
3 Key Laboratory of Cancer Center, Chinese PLA General Hospital, Beijing 100853, China
4 Department of Anesthesiology, Wuxi Third People's Hospital, Wuxi, Jiangsu 214000, China
5 Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
✉
Correspondence to:Hao Wu,haowu017@126.com
✉
Meiqing Lou,loumqdoc@l26.com
#
Co-senior authors
#
Contributed equally.
Collection date 2018 Mar 30.
Copyright: © 2018 Shi et al.
This article is distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
PMCID: PMC5908321 PMID: 29683149
This corrects the article "The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo" on page 706.